Sept 3 (Reuters) - Monopar Therapeutics Inc MNPR.O:
MONOPAR ANNOUNCES ABSTRACT ACCEPTED WITH DISTINCTION FOR ORAL AND POSTER PRESENTATIONS AT THE UPCOMING AMERICAN NEUROLOGICAL ASSOCIATION 2025 ANNUAL MEETING
Source text: ID:nGNX8ts4x8
Further company coverage: MNPR.O
((Reuters.Briefs@thomsonreuters.com;))